ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer’s Disease and Klotho Protein, Carmela Abraham, Ph.D. as Chief Science Officer
October 02, 2023 10:43 ET
|
Advantage Therapeutics Inc.
ADvantage Therapeutics appoints Dr. Carmela Abraham as Chief Science Officer
Renowned Public Health Advisor Jim O’Neill Joins Board of Directors of ADvantage Therapeutics
March 24, 2023 08:45 ET
|
Advantage Therapeutics Inc.
BOCA RATON, Fla. and VIENNA, Austria, March 24, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), which is developing therapies to treat neurodegenerative...